Algert Global LLC Celldex Therapeutics, Inc. Transaction History

Algert Global LLC

  • $4.25 Billion
  • Q4 2024

A detailed history of Algert Global LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 104,337 shares of CLDX stock, worth $2.04 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
104,337
Previous 54,983 89.76%
Holding current value
$2.04 Million
Previous $1.87 Million 41.09%
% of portfolio
0.06%
Previous 0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$23.31 - $32.4 $1.15 Million - $1.6 Million
49,354 Added 89.76%
104,337 $2.64 Million
Q3 2024

Nov 12, 2024
SELL
$32.06 - $44.56 $661,429 - $919,317
-20,631 Reduced 27.28%
54,983 $1.87 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $1.07 Million - $1.39 Million
32,564 Added 75.64%
75,614 $2.8 Million
Q1 2024

May 14, 2024
BUY
$35.22 - $51.88 $1.17 Million - $1.72 Million
33,140 Added 334.41%
43,050 $1.81 Million
Q4 2023

Feb 14, 2024
SELL
$22.61 - $40.65 $427,781 - $769,098
-18,920 Reduced 65.63%
9,910 $393,000
Q3 2023

Nov 13, 2023
SELL
$25.45 - $37.46 $271,042 - $398,949
-10,650 Reduced 26.98%
28,830 $793,000
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $479,914 - $606,508
15,844 Added 67.03%
39,480 $1.34 Million
Q1 2023

May 12, 2023
BUY
$34.78 - $47.43 $533,629 - $727,718
15,343 Added 185.01%
23,636 $850,000
Q4 2022

Feb 13, 2023
SELL
$27.78 - $45.38 $409,477 - $668,901
-14,740 Reduced 64.0%
8,293 $370,000
Q3 2022

Nov 15, 2022
BUY
$22.7 - $37.57 $95,067 - $157,343
4,188 Added 22.22%
23,033 $647,000
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $99,630 - $181,423
4,860 Added 34.75%
18,845 $508,000
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $187,952 - $267,376
6,800 Added 94.64%
13,985 $476,000
Q4 2021

Feb 14, 2022
SELL
$35.68 - $56.27 $34,609 - $54,581
-970 Reduced 11.89%
7,185 $278,000
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $236,087 - $456,598
8,155 New
8,155 $440,000
Q1 2021

May 14, 2021
SELL
$16.19 - $29.91 $177,766 - $328,411
-10,980 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$14.99 - $22.75 $511,009 - $775,547
-34,090 Reduced 75.64%
10,980 $192,000
Q3 2020

Nov 16, 2020
BUY
$9.65 - $15.19 $434,925 - $684,613
45,070 New
45,070 $668,000

Others Institutions Holding CLDX

# of Institutions
196
Shares Held
60.7M
Call Options Held
960K
Put Options Held
675K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $915M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email